| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pediatrics and Preventive Medicine [A. J. N.], Pathology [Z. M. N.], and Gynecology and Obstetrics [W. E. J.], Emory University School of Medicine, Atlanta, Georgia 30303
A large number of epidemiological studies, with a variety of different approaches, have focused in the past decade on the relation of genital herpetic or herpes simplex virus type 2 (HSV-2) infection to cervical cancer. The results reported here of the high frequency of HSV-2 antibodies in young women (
21 years) with cervical carcinoma in situ and in women with dysplasia or carcinoma in situ, matched for various sexual attributes to control women, provide support for a causal relation. Nevertheless, the various laboratory, histopathological, and statistical problems associated with all epidemiological studies conducted to date do not yet permit a firm conclusion to be reached as to the etiological role of the genital virus in cervical carcinogenesis. With improvement in laboratory technology, such as the use of herpes-related cancer antigens or purified HSV-2 typespecific antigens, and with the possible development of protective HSV-2 vaccines, the application of epidemiological approaches will probably be necessary to provide the most finite evidence of causality.
1 Presented at the International Symposium on Human Tumors Associated with Herpesviruses, March 26 to 28, 1973, Bethesda, Md. Supported by Grant VC-71V from the American Cancer Society and Grant CA-11433 from the National Cancer Institute, NIH, USPHS.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |